Literature DB >> 2484582

Metallothionein induction by nonsteroidal antiinflammatory drugs.

K H Summer1, D Klein, N de Ruiter, J Abel.   

Abstract

In the present study we report on the effects of commonly used nonsteroidal antiinflammatory drugs on metallothionein (MT) and MT-I mRNA levels. A single dose of chloroquine (100 mg/kg), diclofenac (100 mg/kg), indomethacin (10 mg/kg), or piroxicam (100 mg/kg) was administered ip to C57B1 mice. After 18 h, MT levels were determined with a Cd-saturation radioassay. MT-I mRNA levels were measured by Northern Blot analyses using a probe containing the mouse MT-I gene. All drugs tested caused an increase in the MT content of the liver but not of the kidneys and lung. The lowest and highest effects were observed with chloroquine (8 times the control value) and diclofenac (18 times), respectively. In accordance with the stimulation of MT synthesis, increased accumulation of hepatic MT-I mRNA could be demonstrated. These results indicate that elevated MT levels may contribute to the effectiveness of nonsteroidal antiinflammatory drugs in the treatment of rheumatoid arthritis (RA).

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2484582     DOI: 10.1007/bf02917248

Source DB:  PubMed          Journal:  Biol Trace Elem Res        ISSN: 0163-4984            Impact factor:   3.738


  11 in total

1.  Determination of Cd-thionein in biological materials: comparative standard recovery by five current methods using protein nitrogen for standard calibration.

Authors:  H H Dieter; L Müller; J Abel; K H Summer
Journal:  Toxicol Appl Pharmacol       Date:  1986-09-30       Impact factor: 4.219

2.  Inhibition of prostaglandin synthesis as a mechanism of action for aspirin-like drugs.

Authors:  J R Vane
Journal:  Nat New Biol       Date:  1971-06-23

3.  Penicillamine may detoxify copper in Wilson's disease.

Authors:  I H Scheinberg; I Sternlieb; M Schilsky; R J Stockert
Journal:  Lancet       Date:  1987-07-11       Impact factor: 79.321

4.  Trace elements and rheumatoid arthritis (RA)--pathogenetic and therapeutic aspects.

Authors:  E Munthe; J Aaseth; E Jellum
Journal:  Acta Pharmacol Toxicol (Copenh)       Date:  1986

5.  Possible role for metallothionein in protection against radiation-induced oxidative stress. Kinetics and mechanism of its reaction with superoxide and hydroxyl radicals.

Authors:  P J Thornalley; M Vasák
Journal:  Biochim Biophys Acta       Date:  1985-01-21

6.  Metallothionein gene expression in mouse tissues by D-penicillamine.

Authors:  C H Mullin; J Abel; D Klein; K H Summer
Journal:  J Trace Elem Electrolytes Health Dis       Date:  1988-03

7.  D-penicillamine induces rat hepatic metallothionein.

Authors:  H E Heilmaier; J L Jiang; H Greim; P Schramel; K H Summer
Journal:  Toxicology       Date:  1986-12-01       Impact factor: 4.221

8.  Ceruloplasmin and metallothionein induction by zinc and 13-cis-retinoic acid in rats with adjuvant inflammation.

Authors:  R J Cousins; M R Swerdel
Journal:  Proc Soc Exp Biol Med       Date:  1985-06

9.  Interleukin 1 regulates human metallothionein gene expression.

Authors:  M Karin; R J Imbra; A Heguy; G Wong
Journal:  Mol Cell Biol       Date:  1985-10       Impact factor: 4.272

10.  Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease.

Authors:  J M Chirgwin; A E Przybyla; R J MacDonald; W J Rutter
Journal:  Biochemistry       Date:  1979-11-27       Impact factor: 3.162

View more
  3 in total

1.  Drug resistance in rheumatology: an area in search of investigators.

Authors:  Frank A Wollheim
Journal:  Curr Rheumatol Rep       Date:  2003-10       Impact factor: 4.592

2.  Immunocytochemically detectable metallothionein in granulation tissue surrounding mucosal ulceration.

Authors:  A G Douglas-Jones; N D Thomas; M E Elmes; B Jasani
Journal:  Histochem J       Date:  1992-01

3.  Rosiglitazone and AS601245 decrease cell adhesion and migration through modulation of specific gene expression in human colon cancer cells.

Authors:  Angelo Cerbone; Cristina Toaldo; Rosalba Minelli; Eric Ciamporcero; Stefania Pizzimenti; Piergiorgio Pettazzoni; Guglielmo Roma; Mario Umberto Dianzani; Chiara Ullio; Carlo Ferretti; Chiara Dianzani; Giuseppina Barrera
Journal:  PLoS One       Date:  2012-06-28       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.